AzTrials
AzTrials

Assessment of Vertical Dimension ChangeNCT07491640

Dynamic Effect of Occlusal Vertical Dimension on Lower Facial Form and Lip Positions

A study testing Occlusal Vertical Dimension Modification (-4mm), Occlusal Vertical Dimension Modification (-2 mm) and Occlusal Vertical Dimension Modification (0 mm) in people with Assessment of Vertical Dimension Change, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effect of increased/decreased occlusal vertical dimension (OVD) on lower facial form and lip position, to analyze variations across gender groups and to analyze variations across age groups. Read more about this study

Who is it for?
Ages 21 to 90 years
Conditions the study is for
Assessment of Vertical Dimension Change
What is being tested?
Occlusal Vertical Dimension Modification (-4mm), Occlusal Vertical Dimension Modification (-2 mm) and Occlusal Vertical Dimension Modification (0 mm)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
1 Jun 2026to 31 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • -Complete edentulous with complete dentures or overdentures

Who cannot join

  • Gross facial asymmetry
  • A history of surgery in the facial area
  • A history of neurologic disorders
  • Ill-fitting dentures
  • Dentures with inaccurate occlusal vertical dimension (OVD)
  • Inability or unwillingness to smile
Show all 9Show fewer
  • Allergy to nitrile, vinyl polysiloxane (VPS) material or photopolymer resins.
  • Presence of facial hair that would interfere with marking reference points on the face
  • Severe class II or class III malocclusion

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The University of Texas Health Science Center at houston

    Houston, Texas, 77030

Other trials in United States

About this study

The purpose of this study is to evaluate the effect of increased/decreased occlusal vertical dimension (OVD) on lower facial form and lip position, to analyze variations across gender groups and to analyze variations across age groups.

Being tested
Occlusal Vertical Dimension Modification (-4mm), Occlusal Vertical Dimension Modification (-2 mm), Occlusal Vertical Dimension Modification (0 mm), Occlusal Vertical Dimension Modification (+2mm), Occlusal Vertical Dimension Modification (+4mm)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Occlusal Vertical Dimension Modification (-4mm)Device

    Participants will undergo fabrication and placement of removable bite splints designed to alter occlusal vertical dimension (OVD). On each side, four discrete reference points will be marked at the lowest point of the orbital margin and the highest point of the external auditory meatus using Whip-Mix reference plane marker.The subject's head position will be leveled with EZ bow laser level device and -4mm OVD color coded bite splints will be randomly placed in position. An image with desktop facial scanner will be taken.

  • Occlusal Vertical Dimension Modification (-2 mm)Device

    Participants will undergo fabrication and placement of removable bite splints designed to alter occlusal vertical dimension (OVD). On each side, four discrete reference points will be marked at the lowest point of the orbital margin and the highest point of the external auditory meatus using Whip-Mix reference plane marker.The subject's head position will be leveled with EZ bow laser level device and -2mm OVD color coded bite splints will be randomly placed in position. An image with desktop facial scanner will be taken.

  • Occlusal Vertical Dimension Modification (0 mm)Device

    Participants will undergo fabrication and placement of removable bite splints designed to alter occlusal vertical dimension (OVD). On each side, four discrete reference points will be marked at the lowest point of the orbital margin and the highest point of the external auditory meatus using Whip-Mix reference plane marker.The subject's head position will be leveled with EZ bow laser level device and 0mm OVD color coded bite splints will be randomly placed in position. An image with desktop facial scanner will be taken.

  • Occlusal Vertical Dimension Modification (+2mm)Device

    Participants will undergo fabrication and placement of removable bite splints designed to alter occlusal vertical dimension (OVD). On each side, four discrete reference points will be marked at the lowest point of the orbital margin and the highest point of the external auditory meatus using Whip-Mix reference plane marker.The subject's head position will be leveled with EZ bow laser level device and +2mm OVD color coded bite splints will be randomly placed in position. An image with desktop facial scanner will be taken.

  • Occlusal Vertical Dimension Modification (+4mm)Device

    Participants will undergo fabrication and placement of removable bite splints designed to alter occlusal vertical dimension (OVD). On each side, four discrete reference points will be marked at the lowest point of the orbital margin and the highest point of the external auditory meatus using Whip-Mix reference plane marker.The subject's head position will be leveled with EZ bow laser level device and +4mm OVD color coded bite splints will be randomly placed in position. An image with desktop facial scanner will be taken.

Study groups in NCT07491640
Study groupRoleWhat they receive
Occlusal Vertical Dimension Modification (-4mm)ExperimentalNot described
Receives: Device: Occlusal Vertical Dimension Modification (-4mm)
Occlusal Vertical Dimension Modification (-2 mm)ExperimentalNot described
Receives: Device: Occlusal Vertical Dimension Modification (-2 mm)
Occlusal Vertical Dimension Modification (0 mm)ExperimentalNot described
Receives: Device: Occlusal Vertical Dimension Modification (0 mm)
Occlusal Vertical Dimension Modification (+2mm)ExperimentalNot described
Receives: Device: Occlusal Vertical Dimension Modification (+2mm)
Occlusal Vertical Dimension Modification (+4mm)ExperimentalNot described
Receives: Device: Occlusal Vertical Dimension Modification (+4mm)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maxillary central incisor length

    Measured: From time of denture placement to about 24 hours after denture placement (depending on patient availibity)

  2. Interlabial gap height

    Measured: From time of denture placement to about 24 hours after denture placement (depending on patient availability)

  3. Intercommisural width

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  4. Distance from Maxillary incisal edge to upper lip in millimeters

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  5. Distance from Maxillary incisal edge to lower lip in millimeters

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  6. Upper lip length

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  7. Upper lip vermilion height

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  8. Lower lip vermilion height

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  9. The upper lip margin on the central incisor to the gingival margin of maxillary central incisor

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  10. The lower lip margin on the central incisor to the gingival margin of mandibular central incisor

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

Secondary outcomes (10)
  1. Maxillary central incisor length

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  2. Interlabial gap height

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  3. Intercommisural width

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  4. Maxillary incisal edge to upper lip

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  5. Maxillary incisal edge to lower lip

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  6. Upper lip length

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  7. Upper lip vermilion height

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  8. Lower lip vermilion height

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  9. The upper lip margin on the central incisor to the gingival margin of maxillary central incisor

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

  10. The lower lip margin on the central incisor to the gingival margin of mandibular central incisor

    Measured: denture placement to about 24 hours after denture placement (depending on patient availability)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2026
  2. Study start1 Jun 2026
  3. Primary completion31 Jul 2026
  4. Study completion31 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
All participants will get all 5 sizes of splints and the order of receipt of each size will be randomized
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07491640
Sponsor's protocol ID
HSC-DB-26-0081
Status last verified
Sep 2026
First submitted
5 Mar 2026
Last updated
11 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Occlusal Vertical Dimension Modification (-4mm), Occlusal Vertical Dimension Modification (-2 mm) and Occlusal Vertical Dimension Modification (0 mm) in people with Assessment of Vertical Dimension Change, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maxillary central incisor length (time frame: From time of denture placement to about 24 hours after denture placement (depending on patient availibity)). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in